[Modern management of the genitourinary syndrome of menopause (GSM)].

Stute, Petra (2021). [Modern management of the genitourinary syndrome of menopause (GSM)]. Therapeutische Umschau, 78(8), pp. 413-420. Huber 10.1024/0040-5930/a001291

[img] Text
34555968_0040-5930_a001291.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.

Download (111kB)

Modern management of the genitourinary syndrome of menopause (GSM) Abstract. Genitourinary syndrome of menopause (GSM) affects up to more than 80 % of postmenopausal women. The diagnosis is purely clinical. Differential diagnosis may require additional laboratory diagnostics. Many therapeutic options are now available internationally (hormone-free vaginal preparations, hormone-containing vaginal preparations, vaginal laser). The choice of therapy depends on the severity of symptoms, the effectiveness and safety of treatments for the individual patient, and the patient's preferences. Long-term studies of the endometrial safety of vaginal estrogen and vaginal dehydroepiandrosterone (DHEA) are not available. Therapy should be continued as long as necessary, i. e., possibly for life. Although the data on hormonal vaginal preparations in breast cancer are insufficient, the international scientific societies are now more open to the use of vaginal estrogen and DHEA.

Item Type:

Journal Article (Review Article)

Division/Institute:

04 Faculty of Medicine > Department of Gynaecology, Paediatrics and Endocrinology (DFKE) > Clinic of Gynaecology

UniBE Contributor:

Stute, Petra

Subjects:

600 Technology > 610 Medicine & health

ISSN:

0040-5930

Publisher:

Huber

Language:

German

Submitter:

Monika Zehr

Date Deposited:

02 Feb 2022 16:32

Last Modified:

05 Dec 2022 16:01

Publisher DOI:

10.1024/0040-5930/a001291

PubMed ID:

34555968

BORIS DOI:

10.48350/163882

URI:

https://boris.unibe.ch/id/eprint/163882

Actions (login required)

Edit item Edit item
Provide Feedback